Dimensional Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$500K Sell
1,126,250
-311,558
-22% -$138K ﹤0.01% 2993
2025
Q1
$814K Sell
1,437,808
-227,305
-14% -$129K ﹤0.01% 2916
2024
Q4
$3.51M Sell
1,665,113
-50,766
-3% -$107K ﹤0.01% 2636
2024
Q3
$4.62M Sell
1,715,879
-111,769
-6% -$301K ﹤0.01% 2536
2024
Q2
$5.21M Sell
1,827,648
-98,678
-5% -$281K ﹤0.01% 2480
2024
Q1
$8.17M Buy
1,926,326
+691
+0% +$2.93K ﹤0.01% 2396
2023
Q4
$10.3M Sell
1,925,635
-8,331
-0.4% -$44.6K ﹤0.01% 2309
2023
Q3
$8.32M Buy
1,933,966
+116,337
+6% +$500K ﹤0.01% 2351
2023
Q2
$9.98M Buy
1,817,629
+72,496
+4% +$398K ﹤0.01% 2259
2023
Q1
$7.33M Buy
1,745,133
+3,985
+0.2% +$16.7K ﹤0.01% 2348
2022
Q4
$4.82K Sell
1,741,148
-1,271
-0.1% -$4 ﹤0.01% 2471
2022
Q3
$4.46M Sell
1,742,419
-135,423
-7% -$347K ﹤0.01% 2467
2022
Q2
$6.76M Sell
1,877,842
-208
-0% -$749 ﹤0.01% 2351
2022
Q1
$11.7M Sell
1,878,050
-5,548
-0.3% -$34.5K ﹤0.01% 2226
2021
Q4
$13.3M Sell
1,883,598
-82,221
-4% -$580K ﹤0.01% 2194
2021
Q3
$13.7M Buy
1,965,819
+10,289
+0.5% +$71.8K ﹤0.01% 2180
2021
Q2
$16.3M Sell
1,955,530
-19,387
-1% -$161K 0.01% 2141
2021
Q1
$10.8M Sell
1,974,917
-52,074
-3% -$285K ﹤0.01% 2296
2020
Q4
$8.7M Sell
2,026,991
-74,083
-4% -$318K ﹤0.01% 2338
2020
Q3
$6.32M Sell
2,101,074
-65,847
-3% -$198K ﹤0.01% 2381
2020
Q2
$6.72M Buy
2,166,921
+8,955
+0.4% +$27.8K ﹤0.01% 2362
2020
Q1
$4.77M Buy
2,157,966
+25,170
+1% +$55.6K ﹤0.01% 2425
2019
Q4
$6.51M Buy
2,132,796
+7,426
+0.3% +$22.6K ﹤0.01% 2519
2019
Q3
$6.54M Buy
2,125,370
+6,617
+0.3% +$20.3K ﹤0.01% 2508
2019
Q2
$4.24M Buy
2,118,753
+71,023
+3% +$142K ﹤0.01% 2691
2019
Q1
$8.83M Buy
2,047,730
+60,641
+3% +$261K ﹤0.01% 2448
2018
Q4
$6.32M Buy
1,987,089
+3,060
+0.2% +$9.73K ﹤0.01% 2525
2018
Q3
$10.4M Buy
1,984,029
+46,089
+2% +$242K ﹤0.01% 2423
2018
Q2
$10.4M Buy
1,937,940
+70,805
+4% +$379K ﹤0.01% 2406
2018
Q1
$9.34M Buy
1,867,135
+101,965
+6% +$510K ﹤0.01% 2402
2017
Q4
$5.83M Buy
1,765,170
+24,380
+1% +$80.5K ﹤0.01% 2565
2017
Q3
$6.53M Buy
1,740,790
+30,068
+2% +$113K ﹤0.01% 2515
2017
Q2
$4.36M Buy
1,710,722
+79,374
+5% +$202K ﹤0.01% 2630
2017
Q1
$4.24M Buy
1,631,348
+20,499
+1% +$53.3K ﹤0.01% 2628
2016
Q4
$4.91M Buy
1,610,849
+1,599
+0.1% +$4.88K ﹤0.01% 2547
2016
Q3
$4.38M Sell
1,609,250
-454
-0% -$1.24K ﹤0.01% 2561
2016
Q2
$4.6M Buy
1,609,704
+14,198
+0.9% +$40.6K ﹤0.01% 2525
2016
Q1
$4.82M Sell
1,595,506
-11,096
-0.7% -$33.5K ﹤0.01% 2503
2015
Q4
$5.58M Sell
1,606,602
-14,368
-0.9% -$49.9K ﹤0.01% 2468
2015
Q3
$6.13M Buy
1,620,970
+56,950
+4% +$215K ﹤0.01% 2424
2015
Q2
$8.92M Buy
1,564,020
+36,258
+2% +$207K 0.01% 2326
2015
Q1
$8.89M Buy
1,527,762
+9,236
+0.6% +$53.8K 0.01% 2296
2014
Q4
$8.61M Buy
1,518,526
+10,947
+0.7% +$62.1K 0.01% 2337
2014
Q3
$6.17M Sell
1,507,579
-13,358
-0.9% -$54.6K ﹤0.01% 2450
2014
Q2
$6.92M Buy
1,520,937
+14,450
+1% +$65.7K ﹤0.01% 2427
2014
Q1
$7.14M Sell
1,506,487
-1,805
-0.1% -$8.56K 0.01% 2392
2013
Q4
$7.09M Sell
1,508,292
-469,707
-24% -$2.21M 0.01% 2391
2013
Q3
$7.89M Sell
1,977,999
-1,397
-0.1% -$5.57K 0.01% 2278
2013
Q2
$7.1M Buy
+1,979,396
New +$7.1M 0.01% 2270